Abstract
From April 2009 to March 2011 in BEACH, benign prostatic hyperplasia/hypertrophy (BPH) was managed at a rate of six per 1000 general practice encounters with male patients aged 18 years and over, suggesting it was managed by general practitioners about 228 000 times per year nationally.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic alpha-1 Receptor Antagonists / therapeutic use
-
Adult
-
Aged
-
Humans
-
Male
-
Middle Aged
-
Prostate-Specific Antigen / blood
-
Prostatic Hyperplasia* / blood
-
Prostatic Hyperplasia* / diagnostic imaging
-
Prostatic Hyperplasia* / drug therapy
-
Referral and Consultation
-
Ultrasonography
Substances
-
Adrenergic alpha-1 Receptor Antagonists
-
Prostate-Specific Antigen